Original Article

You have full text access to this OnlineOpen article

Bone turnover markers and prediction of fracture: A prospective follow-up study of 1040 elderly women for a mean of 9 years

  1. Kaisa K Ivaska1,2,*,
  2. Paul Gerdhem1,3,
  3. H Kalervo Väänänen2,
  4. Kristina Åkesson1,
  5. Karl J Obrant1

Article first published online: 18 DEC 2009

DOI: 10.1359/jbmr.091006

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 25, Issue 2, pages 393–403, February 2010

Additional Information

How to Cite

Ivaska, K. K., Gerdhem, P., Väänänen, H. K., Åkesson, K. and Obrant, K. J. (2010), Bone turnover markers and prediction of fracture: A prospective follow-up study of 1040 elderly women for a mean of 9 years. J Bone Miner Res, 25: 393–403. doi: 10.1359/jbmr.091006

Author Information

  1. 1

    Clinical and Molecular Osteoporosis Research Unit, Lund University, Department of Orthopaedics, Malmö University Hospital, SE-20502 Malmö, Sweden

  2. 2

    University of Turku, Institute of Biomedicine, Department of Cell Biology and Anatomy, FI-20520 Turku, Finland

  3. 3

    Department of Clinical Science, Intervention and Technology, Karolinska Institute, and Department of Orthopaedics, Karolinska University Hospital, SE-14186 Stockholm, Sweden

*University of Turku, Institute of Biomedicine, Department of Cell Biology and Anatomy, Turku, FI-20520, Finland.

Publication History

  1. Issue published online: 19 FEB 2010
  2. Article first published online: 18 DEC 2009
  3. Manuscript Accepted: 9 OCT 2009
  4. Manuscript Revised: 17 AUG 2009
  5. Manuscript Received: 17 MAY 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (337K)

References

  • 1
    Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993; 94: 646–650.
  • 2
    NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. JAMA. 2001; 285: 785–795.
  • 3
    Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; 359: 1761–1767.
  • 4
    Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. WHO Tech Rep Ser 1994; 843: 1–129.
  • 5
    Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996; 312: 1254–1259.
  • 6
    Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20: 1185–1194.
  • 7
    Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004; 34: 195–202.
  • 8
    Wainwright SA, Marshall LM, Ensrud KE, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005; 90: 2787–2793.
  • 9
    Sanders KM, Nicholson GC, Watts JJ, et al. Half the burden of fragility fractures in the community occur in women without osteoporosis: when is fracture prevention cost-effective? Bone. 2006; 38: 694–700.
  • 10
    Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18: 1033–1046.
  • 11
    Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008; 19: 385–397.
  • 12
    Garnero P. Markers of bone turnover for the prediction of fracture risk. Osteoporos Int. 2000; 11: S55–S65.
  • 13
    Gerdhem P, Ivaska KK, Alatalo SL, et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res. 2004; 19: 386–393.
  • 14
    Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res. 1996; 11: 1531–1538.
  • 15
    Bruyere O, Collette J, Delmas P, et al. Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women. Maturitas. 2003; 44: 259–265.
  • 16
    Schousboe JT, Bauer DC, Nyman JA, Kane RL, Melton LJ, Ensrud KE. Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy. Osteoporos Int. 2007; 18: 201–210.
  • 17
    Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD. Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res. 2005; 20: 1813–1819.
  • 18
    Garnero P. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther. 2008; 12: 157–170.
  • 19
    Kakonen SM, Hellman J, Karp M, et al. Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. Clin Chem. 2000; 46: 332–337.
  • 20
    Ivaska KK, Kakonen SM, Gerdhem P, Obrant KJ, Pettersson K, Vaananen HK. Urinary osteocalcin as a marker of bone metabolism. Clin Chem. 2005; 51: 618–628.
  • 21
    Gerdhem P, Akesson K. Rates of fracture in participants and non-participants in the Osteoporosis Prospective Risk Assessment study. J Bone Joint Surg Br. 2007; 89: 1627–1631.
  • 22
    Melton LJ III, Crowson CS, O'Fallon WM, Wahner HW, Riggs BL. Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J Bone Miner Res. 2003; 18: 312–318.
  • 23
    Hannon R, Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int. 2000; 11: S30–S44.
  • 24
    Ivaska KK, Lenora J, Gerdhem P, Akesson K, Vaananen HK, Obrant KJ. Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. J Clin Endocrinol Metab. 2008; 93: 2622–2632.
  • 25
    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000; 15: 1526–1536.
  • 26
    Dobnig H, Piswanger-Solkner JC, Obermayer-Pietsch B, et al. Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements. J Clin Endocrinol Metab. 2007; 92: 1678–1686.
  • 27
    Iki M, Morita A, Ikeda Y, et al. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women: the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int. 2006; 17: 1086–1095.
  • 28
    Hans D, Schott AM, Duboeuf F, Durosier C, Meunier PJ. Does follow-up duration influence the ultrasound and DXA prediction of hip fracture? The EPIDOS prospective study. Bone. 2004; 35: 357–363.
  • 29
    Greenspan SL, Myers ER, Maitland LA, Resnick NM, Hayes WC. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA. 1994; 271: 128–133.
  • 30
    Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone. 2002; 30: 886–890.
View Full Article (HTML) Get PDF (337K)